Results 271 to 280 of about 125,484 (349)

Molecular Fragmentation as a Strategy to Access Hyperpolarized Compounds from Para‐Hydrogen

ChemPhysChem, EarlyView.
Hyperpolarization using para‐hydrogen is a simple and cost‐effective method to dramatically increase sensitivity in magnetic resonance. When combined with chemical reactions that generate smaller fragments, a much wider array of different hyperpolarized molecules can be accessed.
Philip L. Norcott
wiley   +1 more source

Impact of proton pump inhibitors on periodontal health - A systematic review. [PDF]

Saudi Dent J
Aldulaijan HA.
europepmc   +1 more source

Management of uninvestigated dyspepsia: A randomized, double-blind, placebo-controlled trial of proton pump inhibitor therapy

, 2001
Linda Rabeneck, Julianne Souchek, Kimberly Wristers, Terri Menke, Naomi R. Wray, Eunice Ambriz, Iris W. Huang   +6 more
openalex   +1 more source

Commentary: Beware regression to the mean [PDF]

, 2000
Cole, TJ
core  

Implementing Pre‐Emptive Pharmacogenetics: Impact of Early Pharmacogenetic Screening in a Pediatric Oncology Cohort of 1,151 Subjects

Clinical Pharmacology &Therapeutics, EarlyView.
In pediatric oncology, pharmacogenetic guidelines are underutilized and the potential impact of pre‐emptive pharmacogenetic screening remains largely unexplored despite this field's need for individualized approaches. While comprehensive pharmacogenetic guidelines are not yet available for all anticancer drugs, evidence‐based recommendations exist for ...
Emma C. Bernsen, Eugène T.P. Verwiel, Maaike van der Lee, Jesse J. Swen, Marcel Santoso, Leiah J. Brigitha, Rick Admiraal, Bastiaan B.J. Tops, Alwin D.R. Huitema, Patrick Kemmeren, Jayne Y. Hehir‐Kwa, Lidwien M. Hanff, Meta H.M. Diekstra   +12 more
wiley   +1 more source

Proton pump inhibitors in inpatients: Are we getting it right? A retrospective analysis. [PDF]

Qatar Med J
Karuppasamy G, Yahia YMS, Parambil JV, Ismail S, Ibn-Mas'ud Danjuma M.   +4 more
europepmc   +1 more source

Over-the-counter (OTC) H2-receptor antagonists (H2RA) do not compromise the intragastric pH control with proton pump inhibitors (PPI's)

, 2001
Radu Țuțuian, Philip O. Katz, Fawzia Ahmad, Madhu Pamaganamamula, Maria Dipietro, Danald O. Castell   +5 more
openalex   +1 more source

Prevalence of Actionable Pharmacogenetic Genotype Frequencies, Cautionary Medication Use, and Polypharmacy in Community‐Dwelling Older Adults

Clinical Pharmacology &Therapeutics, EarlyView.
Older adults (65 years and over) frequently manage complex medication regimens and are vulnerable to adverse drug reactions and treatment inefficacies, some of which could be preventable with pharmacogenetics (PGx)‐guided prescribing. This study examined the prevalence of actionable PGx genotypes (i.e., those linked to a guideline that recommends a ...
Chad A. Bousman, Ankita Narang, Ziad Al Bkhetan, Robyn L. Woods, Suzanne G. Orchard, Alice J. Owen, Michelle A. Fravel, Julia Gilmartin‐Thomas, Joanne Ryan, Peter D. Fransquet, Rory Wolfe, Chenglong Yu, John J. McNeil, Paul Lacaze, Michael E. Ernst   +14 more
wiley   +1 more source

Exploring the mechanisms and targets of proton pump inhibitors-induced osteoporosis through network toxicology, molecular docking, and molecular dynamics simulations. [PDF]

Front Pharmacol
Mu Y, Zhou Y, Zhang X, Shao Y.
europepmc   +1 more source